miRNEST 2.0: an integrative microRNA resource miRNEST 2.0, an integrative microRNA resource :: Browse



Data derived from PhenomiR


PubMed IDdiseasedisease classtissueexpressionfoldchange maxfoldchange mingenesstudy designmethod
18560586 Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) Cancer ovary miRNA overexpression - 2.66 - Patient study phenotype-control miRNA microarray
17942673 Duchenne muscular dystrophy - 310200 Muscular muscle miRNA overexpression - 6.82 - Patient study phenotype-control miRNA microarray
17942673 Muscular dystrophy, limb-girdle, type 2A - 253600 Muscular muscle miRNA overexpression - 3.08 - Patient study phenotype-control miRNA microarray
17942673 Muscular dystrophy, limb-girdle, type 2B - 253601 Muscular muscle miRNA overexpression - 4.19 - Patient study phenotype-control miRNA microarray
17942673 Miyoshi myopathy - 254130 Muscular muscle miRNA overexpression - 3.25 - Patient study phenotype-control miRNA microarray
17942673 Myopathy, nemaline, 3 - 161800 Muscular muscle miRNA overexpression - 16.47 - Patient study phenotype-control miRNA microarray
17942673 Muscular - 0 (Dermatomyositis - 0) Muscular muscle miRNA overexpression - 3.62 - Patient study phenotype-control miRNA microarray
17998940 Cervical cancer, somatic - 603956 Cancer CaSki cell miRNA downregulation - 4.1 - Cell culture study miRNA microarray
18182067 Muscular - 0 (Uterine leiomyoma - 0) Muscular myoma cell miRNA downregulation - 1.63934 - Patient study phenotype-control miRNA microarray